{
    "clinical_study": {
        "@rank": "50279", 
        "arm_group": {
            "arm_group_label": "Secur-Fit Advanced", 
            "arm_group_type": "Other", 
            "description": "Secur-Fit Advanced Hip Stem"
        }, 
        "brief_summary": {
            "textblock": "This study is a prospective, open-label, post-market, non-randomized, multi-center clinical\n      evaluation of the Secur-Fit Advanced Hip Stem for primary total hip arthroplasty with a\n      cementless application in a consecutive series of patients who meet the eligibility\n      criteria.  The success rate of the Secur-Fit Advanced femoral stem, defined as absence of\n      stem revision for aseptic loosening or femoral fracture, is expected to be no worse than 99%\n      at 5 years postoperative with a non-inferiority margin of 2.5%."
        }, 
        "brief_title": "Secur-Fit Advanced Outcomes Study", 
        "completion_date": {
            "#text": "November 2025", 
            "@type": "Anticipated"
        }, 
        "condition": "Arthroplasty, Replacement, Hip", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient has signed an Institutional Review Board (IRB)/Ethics Committee (EC)\n             approved, study specific Informed Patient Consent Form.\n\n          -  Patient is a male or non-pregnant female, skeletally mature and age 21-75 years at\n             time of study device implantation.\n\n          -  Patient has a diagnosis of Non-Inflammatory Degenerative Joint Disease.\n\n          -  Patient is a candidate for primary total hip arthroplasty.\n\n          -  Patient is willing and able to comply with postoperative scheduled clinical and\n             radiographic evaluations and rehabilitation.\n\n        Exclusion Criteria:\n\n          -  Patient has previously undergone open surgical intervention on the operative hip.\n\n          -  Patient has a prior femoral fracture, with or without deformity, on the operative\n             side.\n\n          -  Patient has an existing total hip replacement on the contralateral side.\n\n          -  Patient requires simultaneous bilateral total hip replacement.\n\n          -  Patient has a Body Mass Index (BMI) > 45.\n\n          -  Patient has an active or suspected latent infection in or about the affected hip\n             joint at time of study device implantation.\n\n          -  Patient has a neuromuscular or neurosensory deficiency that would create an\n             unacceptable risk of instability, prosthesis fixation failure or complications in\n             postoperative care, or which limits the ability to evaluate the safety and efficacy\n             of the device.\n\n          -  Patient has bone stock that is inadequate for support or fixation of the prosthesis,\n             or is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic\n             disorder (e.g. Paget's disease) leading to progressive bone deterioration.\n\n          -  Patient is immunologically suppressed or receiving steroids in excess of normal\n             physiological requirements (e.g. > 30 days).\n\n          -  Patient has a known sensitivity to device materials.\n\n          -  Patient is a prisoner."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "326", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01917929", 
            "org_study_id": "75"
        }, 
        "intervention": {
            "arm_group_label": "Secur-Fit Advanced", 
            "description": "Straight femoral stem intended for cementless, press-fit application.", 
            "intervention_name": "Secur-Fit Advanced Hip Stem", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "[E04.555.110.110.110]", 
        "lastchanged_date": "February 27, 2014", 
        "location": [
            {
                "contact": {
                    "email": "cplacencia@tucsonortho.com", 
                    "last_name": "Crystal Placencia", 
                    "phone": "520-784-6430"
                }, 
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85712"
                    }, 
                    "name": "Tucson Orthopaedic Institute"
                }, 
                "investigator": {
                    "last_name": "Russell Cohen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "CAndreoni@aboutsmh.org", 
                    "last_name": "Colette Andreoni", 
                    "phone": "815-663-8009"
                }, 
                "facility": {
                    "address": {
                        "city": "Spring Valley", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "61362"
                    }, 
                    "name": "Family Orthopedic Center"
                }, 
                "investigator": {
                    "last_name": "Paul Perona, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "bolesj@hss.edu", 
                    "last_name": "John Boles", 
                    "phone": "212-639-9266"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Hospital for Special Surgery"
                }, 
                "investigator": {
                    "last_name": "Geoffrey Westrich, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jennifer.friend@duke.edu", 
                    "last_name": "Jennifer Friend", 
                    "phone": "919-668-4373"
                }, 
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27703"
                    }, 
                    "name": "Duke University Medical Center"
                }, 
                "investigator": {
                    "last_name": "Samuel Wellman, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Secur-Fit Advanced Hip Stem", 
        "overall_contact": {
            "email": "alice.cruz@stryker.com", 
            "last_name": "Alice Cruz", 
            "phone": "201-831-5859"
        }, 
        "overall_contact_backup": {
            "email": "catherine.vanacore@stryker.com", 
            "last_name": "Catherine Vanacore", 
            "phone": "201-831-5893"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of revision for aseptic loosening or femoral fracture", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01917929"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "All-cause revision and removal rate", 
                "safety_issue": "Yes", 
                "time_frame": "10 years"
            }, 
            {
                "measure": "Rate of femoral fracture", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "source": "Stryker Orthopaedics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Stryker Orthopaedics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}